Public Company News & Press Release Distribution

2026 ASCO | Innovent Presents Long-Term Follow-up Results from the PoC Study of IBI363 (TAK-928) (PD-1/IL-2α-bias bispecific fusion protein), Showing Robust Survival Benefits in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancer

* After long-term follow-up, IBI363 monotherapy demonstrated strong overall survival (OS) with a long tail effect in IO-resistant squamous NSCLC and adenoNSCLC * IBI363 has entered a global Phase 3 clinical study (MarsLight-11) for IO-resistant squamous NSCLC; pending regulatory communication...

2026-06-01 08:00 3799

2026 ASCO | Innovent Presents Long-Term Follow-up Results from the PoC Study of IBI363 (TAK-928) (PD-1/IL-2α-bias bispecific fusion protein), Showing Robust Survival Benefits in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancer

HARMONi-6 Demonstrates Significant Overall Survival Benefit (HR=0.66): Ivonescimab Plus Chemotherapy Superior to PD-1 Plus Chemotherapy in First-Line sq-NSCLC Landmark Results to Be Presented at ASCO 2026 Plenary Session

CHICAGO, May 31, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that ivonescimab, the Company's first-in-class PD-1/VEGF bispecific antibody, has achieved a statistically significant and clinically meaningful improvement in overall survival (OS) as a first-l...

2026-05-31 21:00 3342

Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026

* Oral presentation of DZD6008 demonstrated strong and durable anti-tumor activity, excellent BBB-penetrant properties, and a favorable safety profile in patients relapsed from third-generation EGFR TKI * In treatment-naïve patients with advanced NSCLC without driver mutations, Golidocitinib,...

2026-05-31 08:09 5268

Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet

CHENGDU, China, May 31, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that the results of the Phase III clinical study OptiTROP-Lung05, evaluating the company's trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug con...

2026-05-31 08:00 6396

Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet

The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet

CHENGDU, China, May 30, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, the results of the Phase III clinical study OptiTROP-Lung05, evaluating...

2026-05-30 22:01 6958

The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet

Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO

CHENGDU, China, May 30, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced that at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, USA, results from the pivotal Phase II study of the Company's next-genera...

2026-05-30 21:51 6621

Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO

Creality Charts Next Decade as AI-Powered Consumer 3D Creative Platform, Hong Kong listing anchors the company's full-stack ecosystem shift

HONG KONG, May 30, 2026 /PRNewswire/ -- As an emerging segment at the intersection of intelligent manufacturing and creative consumption, the global consumer 3D printing industry has become one of the fastest-growing markets in consumer technology. According to China Insights Industry Consultancy...

2026-05-30 11:58 12849

Creality Charts Next Decade as AI-Powered Consumer 3D Creative Platform, Hong Kong listing anchors the company's full-stack ecosystem shift

CLPS Incorporation Receives Nasdaq Notification Regarding Minimum Bid Price Requirements

HONG KONG, May 29, 2026 /PRNewswire/ -- CLPS Incorporation (the "Company" or "CLPS") (Nasdaq: CLPS) today announced that it received a notification letter (the "Notification Letter") from Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") dated May 27, 2026, indicating th...

2026-05-30 08:16 3940

OCI Global Q1 2026 Trading Update

AMSTERDAM, May 30, 2026 /PRNewswire/ -- Hassan Badrawi, CEO of OCI Global: "During the first quarter, OCI made continued progress in executing its strategic priorities, including the completion of the sale of OCI Ammonia Holding to AGROFERT, the handover of Beaumont New Ammonia to Woodside, and t...

2026-05-30 00:35 5541

XCMG Secures Over $1 Billion in Orders at 8th International Customer Festival, Expanding Global Partnerships

XUZHOU, China, May 30, 2026 /PRNewswire/ -- XCMG concluded its 8th International Customer Festival, held from May 19 to 23 in Xuzhou, with more than 2,500 customers and business partners from around the world in attendance. During the event, signed orders exceeded US$1 billion, setting a new reco...

2026-05-30 00:30 9278

XCMG Secures Over $1 Billion in Orders at 8th International Customer Festival, Expanding Global Partnerships

AMTD's Successful Completion of Acquisition of Upper View Regalia Hotel in Malaysia for US$38 Million

PARIS and NEW YORK and LONDON, May 29, 2026 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE: AMTD; SGX: HKB), AMTD Digital Inc. (NYSE: HKD), and The Generation Essentials Group ("TGE", NYSE: TGE; LSE: TGE), a subsidiary of AMTD Digital Inc., (collectively, "AMTD") jointly an...

2026-05-29 23:07 6875

Lanvin Names Barbara Werschine as CEO

SHANGHAI, May 29, 2026 /PRNewswire/ -- Lanvin Group (NYSE: LANV), a global luxury fashion group, today announced that Maison Lanvin, the oldest couture house in Paris, has appointed Barbara Werschine as Chief Executive Officer. Ms. Werschine is an accomplished leader in the international luxury s...

2026-05-29 22:32 6065

Lanvin Names Barbara Werschine as CEO

SHANGHAI, May 29, 2026 /PRNewswire/ -- Lanvin Group (NYSE: LANV), a global luxury fashion group, today announced that Maison Lanvin, the oldest couture house in Paris, has appointed Barbara Werschine as Chief Executive Officer. Ms. Werschine is an accomplished leader in the international luxury s...

2026-05-29 22:29 5086

XtalPi Receives Second Payment from DoveTree; First Oncology Asset Advances into IND-Enabling Studies

BOSTON, May 29, 2026 /PRNewswire/ -- XtalPi (2228.HK), an AI- and robotics- powered drug discovery platform, announced that its strategic collaboration with innovative biopharmaceutical company DoveTree Medicines Unus Inc. has achieved substantial progress, and that XtalPi has received the second...

2026-05-29 22:10 5864

Cyient Named Leader Across All Three Quadrants of ISG Provider Lens™ 2026 Digital Engineering Services Report for North America

Company achieves clean sweep of all three quadrants — Augmented Design & R&D Services, Intelligent Operations & Connected Experiences, and Integrated Platform & Application Services — in the United States region HYDERABAD, India, May 29, 2026 /PRNewswire/ -- Cyient Limited, a global Intelligent ...

2026-05-29 22:00 5093

Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering

SHANGHAI, May 29, 2026 /PRNewswire/ -- Zhongchao Inc. ("Zhongchao" or the "Company") (NASDAQ: ZCMD), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced the pricing of a best efforts public offering with gross proceeds ...

2026-05-29 22:00 7724

AMTD's Successful Completion of Acquisition of The Ritz-Carlton, Perth, Valued at A$280 Million

PARIS and NEW YORK and LONDON, May 29, 2026 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE: AMTD; SGX: HKB), AMTD Digital Inc. (NYSE: HKD), and The Generation Essentials Group ("TGE", NYSE: TGE; LSE: TGE), a subsidiary of AMTD Digital Inc., (collectively, "AMTD") jointly an...

2026-05-29 21:50 10228

AMTD's Successful Completion of Acquisition of The Ritz-Carlton, Perth, Valued at A$280 Million

Acer Unveils Sub-1kg TravelMate P6 14 AI Business Laptop with New Acer Comfort Touch Design for Premium Luxury on the Move

Lineup also deploys new Intel Core Series 3 processors on business laptops for the first time across form factors Editor's Summary * The Acer TravelMate P6 14 AI is a Windows 11 Copilot+ PC powered by Intel Core Ultra Series 3 processors with Intel vPro, delivering 150 TOPS of platform AI pow...

2026-05-29 21:30 5993

New Acer Tablets Plus AI and AR Glasses Expand On-the-Go Capabilities

Editor's Summary * The Acer Iconia Duo S14 is a premium 14.2-inch 2.8K 3:2 OLED tablet powered by the MediaTek Dimensity 8300 SoC and Android 16, designed as the ultimate creative and productivity hub for elite professionals. * The Acer Iconia Duo S12 is a 12.2-inch 2.8K 3:2 OLED premium tabl...

2026-05-29 21:25 5742

Acer Introduces Predator Helios 18 AI: The Ultimate Gaming Laptop

Gaming lineup also includes the Acer Nitro 16 laptop, the Acer Nitro Blaze Link streaming handheld device, and accessories for leveling up gaming experiences Editor's Summary * Winner of the iF Design Award 2026, the Predator Helios 18 AI gaming laptop delivers ultimate performance with up to ...

2026-05-29 21:10 3955